An Emergency Medicine Broadsheet
·Phoenix·
Est. MMXXVI
Blue Fish Med · Today's Topic
Hypocalcemia
Acute hypocalcemia can cause seizures, laryngospasm, and malignant dysrhythmias. The key is to treat the dangerous physiology promptly while identifying a reversible cause.
Also known aslow calcium · calcium deficiency · tetany
A 36-year-old woman is six hours out from thyroid surgery when she presses the call button because her lips feel numb. Her fingers have curled inward around the blanket, and the monitor’s high-pitched alarm sounds as the QT interval lengthens. She is awake, frightened, and breathing quickly. The next move is still yours.
— What’s your move? Read on.
Before you read
What should you check before assuming the calcium is the whole story?
Which calcium preparation is safest through a peripheral IV?
When to Think of It
Perioral or distal paresthesias, cramps, carpopedal spasm, tetany, seizures, stridor, or QT prolongation—especially after neck surgery, massive transfusion, pancreatitis, or in renal disease. Confirm with ionized calcium when symptoms, critical illness, or abnormal albumin make total calcium unreliable.
Sick or Not Sick
The fork is symptomatic/severe hypocalcemia or ECG instability versus mild, stable, asymptomatic low calcium. Seizure, tetany, laryngospasm, arrhythmia, or marked QT prolongation calls for IV calcium now.
The First Fifteen Minutes
Obtain ECG and check ionized calcium, magnesium, phosphate, renal function, and albumin; do not delay treatment for results if there is tetany, seizure, or dysrhythmia.
Symptomatic hypocalcemia or significant ECG change → calcium gluconate 1–2 g IV (10% solution) over 10–20 minutes, with ECG monitoring; repeat according to symptoms and ionized calcium because it rapidly raises extracellular calcium.
Unstable patient with central access → calcium chloride 1 g IV (10% solution) over 10 minutes may be used instead; it delivers more elemental calcium but can cause severe tissue injury if extravasated.
Mild, stable symptoms without ECG change → calcium carbonate 1–2 g elemental calcium PO, divided as tolerated; oral absorption replenishes calcium without an urgent IV bolus. Check the product’s elemental-calcium content.
If hypomagnesemia is present, replace it: magnesium sulfate 1–2 g IV over 1 hour for a stable patient; magnesium is needed for PTH secretion and action.
Definitive Care & Disposition
Repeat ionized calcium and ECG after IV replacement; identify and treat the cause (e.g., postoperative hypoparathyroidism, renal disease, pancreatitis, or citrate load). Persistent symptoms, need for repeated IV calcium, seizure, dysrhythmia, or significant airway symptoms generally require admission—often monitored or ICU care. Add oral calcium and calcitriol for ongoing hypoparathyroidism with specialist input.
How This One Kills
Treating a low total calcium without checking ionized calcium—or treating calcium while missing low magnesium—can lead to ineffective replacement and ongoing tetany or dysrhythmia.
The Differential — What Else Looks Like This
Hyperventilation-induced paresthesias — alkalosis lowers ionized calcium despite a near-normal total calcium; missing the cause can leave the patient symptomatic.
Hypomagnesemia — can cause tetany and impair PTH; calcium alone may not correct it.
Focal seizure — persistent focal findings or postictal state are not explained by uncomplicated hypocalcemia; anchoring can miss intracranial disease.
Trousseau-like symptoms from anxiety — a normal ionized calcium and ECG favor this; unnecessary IV calcium has its own risks.
The Second-Day Story
Older adults may present with confusion, weakness, falls, or a seizure rather than classic perioral tingling; postoperative patients may have symptoms before a total-calcium result flags abnormal. Alkalosis can further lower ionized calcium and amplify symptoms. Use the ECG, ionized calcium, and magnesium to assess the physiology rather than relying on the total calcium alone.
Back to Our Patient
Back to our 36-year-old six hours after thyroid surgery: the perioral numbness, carpopedal spasm, and lengthening QT make symptomatic hypocalcemia the leading concern. Recognize the high-risk presentation, risk-stratify her as requiring immediate treatment, and obtain an ECG and ionized calcium while checking magnesium and phosphate. Give calcium gluconate 1–2 g IV over 10–20 minutes with cardiac monitoring, reassess symptoms and ECG, and repeat calcium-guided treatment if needed. Her postoperative cause and need for IV replacement warrant admission for monitoring and definitive calcium management.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
“This is a 36-year-old woman, six hours after thyroid surgery, with new perioral numbness and painful hand cramping. Symptoms began this hour and are worsening; she has no syncope, chest pain, or known seizure. She is alert, with carpopedal spasm and a prolonged QT on ECG, but no stridor or respiratory distress. Her ionized calcium and magnesium are pending. I’m concerned for acute symptomatic postoperative hypocalcemia, with hypomagnesemia also possible. I’m placing her on cardiac monitoring, giving IV calcium gluconate, and will reassess her ECG and ionized calcium while arranging admission.”
Study Directive
From memory, list three clinical indications for IV rather than oral calcium.
Practice converting a calcium gluconate dose into grams of salt and identify the need for ionized calcium in a critically ill patient.
Review how magnesium deficiency disrupts PTH secretion/action and write a one-line treatment plan for refractory hypocalcemia.
A focused guide to confirming hypocalcemia, identifying its cause, and treating severe or symptomatic cases with calcium replacement.
More in Today's Issue
3 additional topics
2 of 4
Electrolyte Repletion
Electrolyte replacement can prevent seizures, dysrhythmias, respiratory failure, and weakness—but overly rapid or mismatched replacement can cause the same....
Also known aselectrolyte replacement · electrolyte supplementation · potassium repletion · magnesium repletion
A 71-year-old man with poor oral intake is found on the floor after a day of worsening weakness. His hands are cool, his legs tremble when he tries to stand, and the first chemistry panel begins to populate on the computer. He is awake and speaking, but his telemetry tracing is not yet reassuring. Before replacing anything, you have to decide what matters most.
Before You Read
Which electrolyte abnormality is immediately dangerous—and what tells you that?
Which replacement route and rate fit the severity?
What can go wrong if you choose the wrong salt or replace too quickly?
Why It Matters
Electrolyte replacement can prevent seizures, dysrhythmias, respiratory failure, and weakness—but overly rapid or mismatched replacement can cause the same. The ECG, symptoms, renal function, and rate of change matter as much as the lab value.
When to Think of It
Consider urgent replacement with arrhythmia, ECG change, seizure, significant weakness, respiratory compromise, or a very low/rapidly falling level. Check renal function, urine output, medications, acid–base status, and relevant paired electrolytes; repeat unexpected results to exclude artifact without delaying care in an unstable patient.
Sick or Not Sick
The fork is electrical, neurologic, or respiratory instability versus stable deficiency. An unstable patient gets monitored, targeted replacement; a stable patient with functioning gut and no severe deficit is usually safer with oral replacement.
The First Fifteen Minutes
Place unstable patients on cardiac monitoring; obtain ECG, metabolic panel, magnesium, phosphate, and ionized calcium as indicated. Identify the deficient electrolyte and avoid reflexively replacing every abnormal value.
Severe/symptomatic hypokalemia, or inability to take oral medication → potassium chloride 10 mEq IV per hour through a peripheral line; use a higher rate only with appropriate central access, continuous monitoring, and local protocol. Potassium restores myocardial and neuromuscular function; never give IV push.
Stable hypokalemia with a functioning gut → potassium chloride 40 mEq PO; oral replacement is safer and usually preferred. Recheck and repeat based on level, renal function, and ongoing losses.
Severe hypomagnesemia with seizure or dysrhythmia → magnesium sulfate 2 g IV over 10–15 minutes with monitoring; rapid replacement addresses a potentially arrhythmogenic deficit. For stable symptomatic deficiency, use 1–2 g IV over 1 hour.
Severe symptomatic hypophosphatemia (e.g., respiratory weakness, seizure, or profound depletion) → sodium or potassium phosphate 15 mmol IV over 4–6 hours, selected according to serum potassium and renal function; phosphate restores cellular energy substrate. Dose and infusion rate vary—check institutional protocol or a dosing reference.
Symptomatic hypocalcemia or ECG change → calcium gluconate 1–2 g IV over 10–20 minutes with monitoring; it promptly raises extracellular calcium.
Reduce or withhold replacement for significant renal impairment, oliguria, or a high/rapidly rising level unless a specialist-guided emergency indication exists.
Definitive Care & Disposition
Repeat levels after IV replacement and continue in smaller, reassessed increments; correct ongoing losses and causes such as diuretics, GI losses, alcohol use, or refeeding. Replace magnesium when hypokalemia or hypocalcemia is refractory. Admit patients needing IV replacement, with severe deficits, ECG changes, poor oral intake, significant renal dysfunction, or unreliable follow-up; discharge only when clinically well, repletion is safe orally, and repeat testing is arranged.
How This One Kills
Giving large, unmonitored replacement doses in renal impairment can turn a deficit into a fatal excess; chasing a lab number without reassessing the patient and repeat level is the failure mode.
The Atypical Presentation
Older adults may present with falls, delirium, or nonspecific weakness, and patients with poor intake may have several simultaneous deficits. A normal-looking ECG does not exclude clinically important depletion, while a mildly abnormal value may not explain severe symptoms. Look for the pattern—especially low potassium, magnesium, and phosphate after nutrition is restarted—and use serial levels and renal function to guide cautious replacement.
Back to Our Patient
Back to our 71-year-old man with cool hands and trembling legs: first assess perfusion, ECG, and the actual electrolyte pattern rather than treating the first flagged result in isolation. If he has ECG change or severe symptoms, place him on monitoring and prioritize the dangerous deficit, using an appropriate route and rate; assess renal function and urine output before replacement. Replace coexisting magnesium or phosphate deficits carefully and repeat levels to verify response. Given his weakness, poor intake, and need for monitored replacement, admit for continued evaluation and repletion.
Patient Presentation to Attending
“This is a 71-year-old man with poor oral intake and a day of worsening generalized weakness, found on the floor. He is awake and speaking, without focal symptoms, but is tremulous when attempting to stand. His initial electrolytes show [key abnormalities], with [key ECG finding] and [renal function/urine output]. I’m concerned about clinically significant electrolyte depletion, potentially involving more than one electrolyte. I’ve placed him on monitoring, am checking the ECG and renal function, and will replace the highest-risk deficit by an appropriate route and rate with repeat levels. He needs admission for monitored repletion and evaluation of the cause.”
Study Directive
Write a bedside replacement plan for low potassium, magnesium, phosphate, and ionized calcium, including monitoring and repeat testing.
Practice choosing potassium versus sodium phosphate in three sample cases with different potassium and renal-function results.
Review your local IV electrolyte concentrations, maximum infusion rates, and monitoring requirements.
Key Medications
Potassium chloride: 40 mEq PO for stable replacement; IV at 10 mEq/hour peripherally. Rates up to 20 mEq/hour generally require central access and continuous monitoring; faster rates are institution-specific and need a dosing reference/protocol.
Magnesium sulfate: 1–2 g IV over 1 hour for stable symptomatic deficiency; 2 g IV over 10–15 minutes for severe symptoms/dysrhythmia. Adjust for renal impairment.
Sodium/potassium phosphate: commonly 15 mmol IV over 4–6 hours for severe deficiency; dose, salt choice, and repeat dosing vary with level, renal function, and potassium—check Lexicomp, UpToDate, or institutional protocol.
Calcium gluconate: 1–2 g IV over 10–20 minutes for symptomatic hypocalcemia.
Pediatric replacement is weight-based and requires pediatric-specific concentrations and maximum doses.
High-Yield Pearls
In oliguria or acute kidney injury, a routine replacement dose can become an overdose; check urine output, not just creatinine.
Phosphate replacement can lower calcium, while potassium phosphate can worsen hyperkalemia—choose the salt based on the whole panel.
The Mimics
Pseudohypokalemia from delayed sample processing — repeat a suspicious result; treating a spurious level can cause hyperkalemia.
Low total calcium from hypoalbuminemia — ionized calcium distinguishes biologically active deficiency; unnecessary IV calcium can harm.
Hypophosphatemia from refeeding — recent nutritional restart and concurrent potassium/magnesium decline signal a systemic intracellular shift; isolated phosphate replacement misses the broader risk.
Weakness from neurologic disease — focal deficits or a discordant electrolyte level require a neurologic evaluation; attributing weakness to a lab abnormality can delay time-critical care.
Board Question
A patient with severe hypokalemia has ongoing weakness despite potassium replacement. Which accompanying deficiency most commonly makes potassium repletion difficult? -
AHypomagnesemia -
BHyperphosphatemia -
CHypercalcemia -
DHypernatremia
Reveal answer
Correct: A
Magnesium deficiency promotes renal potassium wasting, so potassium may remain low until magnesium is corrected. Recheck both levels and replace cautiously based on renal function.
3 of 4
Euglycemic DKA
A near-normal glucose can conceal dangerous ketoacidosis, particularly with SGLT2 inhibitor exposure, pregnancy, fasting, or partial insulin treatment....
Also known aseDKA · euglycemic diabetic ketoacidosis · SGLT2 inhibitor-associated ketoacidosis · ketoacidosis without hyperglycemia
A 29-year-old woman with type 1 diabetes arrives after a day of vomiting and abdominal discomfort. Her breath smells faintly sweet, and she keeps asking for water, but the bedside glucose is only 184 mg/dL. She has been unable to keep down food and has continued taking her usual medicines. The reassuring number is not the end of the workup.
Before You Read
What confirms ketoacidosis when glucose is not markedly elevated?
When should insulin start, and what must be checked first?
Why might dextrose be needed before glucose becomes low?
Why It Matters
A near-normal glucose can conceal dangerous ketoacidosis, particularly with SGLT2 inhibitor exposure, pregnancy, fasting, or partial insulin treatment. Delayed recognition can allow acidosis and dehydration to worsen while clinicians are reassured by the glucose.
When to Think of It
Suspect euglycemic DKA with nausea, vomiting, abdominal pain, malaise, or tachypnea in a patient with diabetes or SGLT2 inhibitor use—even with glucose below 250 mg/dL. Look for anion-gap metabolic acidosis, elevated serum beta-hydroxybutyrate, and low bicarbonate/pH; urine ketones can underestimate beta-hydroxybutyrate.
Sick or Not Sick
The fork is ketotic high-anion-gap acidosis requiring insulin and close monitoring versus ketosis without DKA. Assess pH, bicarbonate, beta-hydroxybutyrate, potassium, volume status, mental status, pregnancy, infection, and renal function.
The First Fifteen Minutes
Stop the SGLT2 inhibitor and assess for triggers, including infection, missed insulin, fasting, and pregnancy. Obtain glucose, electrolytes, venous blood gas, anion gap, beta-hydroxybutyrate, urinalysis, and pregnancy testing when relevant.
Volume depletion without heart failure or advanced renal disease → balanced crystalloid 1–1.5 L IV in the first hour, then reassess; restore circulating volume and renal perfusion. Use smaller boluses and frequent reassessment in patients at risk of overload.
Potassium below 3.5 mEq/L → potassium chloride 10 mEq/hour IV with monitoring; hold insulin until potassium is above 3.5 because insulin can drive potassium into cells and provoke arrhythmia. If potassium is 3.5–5.0, add 20–30 mEq potassium per liter of fluid to maintain a level around 4–5, guided by repeat tests and renal function.
Confirmed DKA with potassium above 3.5 → regular insulin 0.1 units/kg/hour IV, without a bolus, with frequent glucose and electrolyte checks; insulin suppresses ketogenesis and stops further acid production.
Euglycemic DKA at insulin initiation → add dextrose-containing fluid (typically D5; use D10 if needed) from the outset, titrating to keep glucose roughly 150–200 mg/dL while insulin continues to clear ketones. Do not stop insulin just because glucose is normal.
Definitive Care & Disposition
Continue insulin and dextrose until ketoacidosis resolves—not merely until glucose normalizes—and follow serial beta-hydroxybutyrate, pH/bicarbonate, potassium, and volume status. Treat the precipitant; do not restart an SGLT2 inhibitor during the acute episode. ICU care is appropriate for severe acidosis, shock, altered mental status, or critical precipitating illness; otherwise admit to a monitored setting able to manage an insulin infusion. Transition to subcutaneous insulin with overlap before stopping IV insulin.
How This One Kills
Stopping insulin—or never starting it—because glucose is near normal leaves ketone production unchecked and acidosis progressing.
The Atypical Presentation
Patients taking SGLT2 inhibitors may have significant ketosis and acidosis with only modest hyperglycemia, and pregnancy or prolonged fasting can further blunt the glucose signal. Vomiting, dehydration, and nonspecific malaise may dominate; urine ketones can be weak or misleading because they do not directly measure beta-hydroxybutyrate. Check blood ketones and acid–base status when the clinical context fits.
Back to Our Patient
Back to our 29-year-old with vomiting, sweet-smelling breath, and glucose of 184 mg/dL: her diabetes and symptoms should trigger evaluation for ketotic acidosis, not reassurance from the glucose. Confirm the anion-gap acidosis and elevated beta-hydroxybutyrate, assess volume and potassium, and risk-stratify the severity. If potassium is above 3.5 mEq/L, begin IV regular insulin with dextrose-containing fluid from the outset; if lower, replace potassium first and defer insulin. Admit for monitored therapy until ketosis and acidosis resolve, then transition safely to subcutaneous insulin.
Patient Presentation to Attending
“This is a 29-year-old woman with type 1 diabetes, one day of vomiting and abdominal discomfort, and a bedside glucose of 184. She has been unable to eat but reports continuing her usual medicines; she has no focal neurologic symptoms. She is [vital signs], with [volume status] and [respiratory pattern]; her labs show [anion gap], bicarbonate [value], pH [value], and beta-hydroxybutyrate [value]. I’m concerned for euglycemic DKA, with [potassium] determining whether insulin can start now. I’m giving IV crystalloid, will add dextrose with the insulin infusion, and will replace potassium first if it is below 3.5. She needs admission for serial labs and treatment until the acidosis and ketosis resolve.”
Study Directive
From memory, state the diagnostic pattern for DKA and why euglycemic cases are missed.
Work through a sample treatment sequence that includes potassium-first logic, insulin initiation, and dextrose titration.
Review your institutional DKA protocol and identify its potassium threshold, insulin transition overlap, and criteria for resolution.
Key Medications
Regular insulin: 0.1 units/kg/hour IV for DKA once potassium is above 3.5 mEq/L; monitor glucose and electrolytes closely.
Dextrose: D5-containing IV fluid at insulin initiation in euglycemic DKA; titrate fluid concentration/rate to glucose while maintaining insulin. Exact fluid selection depends on volume status and protocol.
Potassium chloride: If K <3.5 mEq/L, 10 mEq/hour IV and defer insulin until corrected; if K 3.5–5.0, commonly add 20–30 mEq/L to IV fluid. Adjust for renal function and local protocol.
Crystalloid: 1–1.5 L IV in the first hour for adults without risk of overload; use smaller boluses when heart or kidney disease warrants.
Pediatric DKA fluid and insulin protocols differ substantially; use a pediatric protocol.
High-Yield Pearls
A negative or weak urine ketone result does not rule out early DKA; serum beta-hydroxybutyrate is the better test.
In a patient on an SGLT2 inhibitor, vomiting plus unexplained acidosis deserves ketone testing even when glucose is normal.
The Mimics
Starvation ketosis — usually less severe acidosis and improves with carbohydrate; confusing it with DKA can delay needed insulin.
Alcoholic ketoacidosis — alcohol history, poor intake, and often low/normal glucose favor it; insulin without careful evaluation can cause hypoglycemia.
Lactic acidosis — elevated lactate explains the anion gap, not significant beta-hydroxybutyrate; missing concurrent DKA leaves ketogenesis untreated.
Toxic alcohol ingestion — osmolar gap, exposure history, and visual or renal findings may distinguish it; anchoring on diabetes can miss a toxic ingestion.
Board Question
A patient taking an SGLT2 inhibitor has vomiting, an anion-gap acidosis, elevated beta-hydroxybutyrate, and glucose of 176 mg/dL. Which approach is best? -
ADischarge because glucose is below 250 mg/dL -
BGive insulin only if glucose rises above 250 mg/dL -
CStart insulin with dextrose-containing fluid after checking potassium -
DGive bicarbonate as the sole treatment
Reveal answer
Correct: C
Euglycemic DKA is still DKA: insulin is required to stop ketogenesis, while dextrose permits insulin to continue without causing hypoglycemia. Check potassium first and correct it before insulin if it is below 3.5 mEq/L.
A normal or mildly elevated glucose level does not exclude DKA; check ketones and the anion gap, and give dextrose alongside insulin during treatment.
4 of 4
Insulin Pumps
Most pumps deliver only rapid-acting insulin, so interruption can lead to ketosis within hours. Continuing an unfamiliar or malfunctioning pump during...
Also known ascontinuous subcutaneous insulin infusion · CSII · insulin pump therapy
A 24-year-old man with type 1 diabetes is brought in after two days of fever and nausea. A small device clipped to his waistband vibrates while he lies on the stretcher, and he says he has not changed the tubing since yesterday. His glucose is high, but the number alone does not explain how quickly he became ill. You need to decide what to do with the device—and his insulin.
Before You Read
When is it unsafe to let a patient continue using their pump in the ED?
What is the danger of simply turning it off?
How do you maintain insulin coverage if the pump must be stopped?
Why It Matters
Most pumps deliver only rapid-acting insulin, so interruption can lead to ketosis within hours. Continuing an unfamiliar or malfunctioning pump during critical illness can also cause unrecognized dosing errors.
When to Think of It
Ask about pump type, last infusion-set change, alarms, recent delivery, basal settings, boluses, continuous glucose monitor (CGM) readings, and available supplies. Suspect interruption or delivery failure with unexplained hyperglycemia, ketones, nausea, or acidosis; verify CGM readings with point-of-care glucose when decisions are urgent.
Sick or Not Sick
The fork is patient able to safely self-manage a functioning pump versus impaired/critically ill patient, pump failure, or DKA. DKA, altered mental status, shock, inability to operate the device, or suspected malfunction means stop pump-dependent management and use hospital-directed insulin.
The First Fifteen Minutes
Check point-of-care glucose, electrolytes, venous blood gas, ketones, pump display/alarms, and infusion site; determine whether the patient has actually received insulin. Treat the patient, not the device.
Pump user with hypoglycemia who is awake and able to swallow → oral glucose 15–20 g PO and recheck glucose in 15 minutes; temporarily suspend or reduce delivery if the pump is continuing insulin and the patient can safely manage it.
Severe hypoglycemia with IV access or impaired consciousness → dextrose 25 g IV (e.g., 250 mL D10 or 50 mL D50, depending on local formulation); it rapidly restores circulating glucose. If no IV access, glucagon 1 mg IM or SC is an alternative, though response may be poor with depleted glycogen stores.
Pump-related DKA and potassium above 3.5 mEq/L → stop/disconnect the pump and start regular insulin 0.1 units/kg/hour IV; pump delivery is unreliable in DKA, while IV insulin suppresses ketogenesis predictably. Add dextrose as glucose approaches 250 mg/dL, or earlier if euglycemic.
DKA with potassium below 3.5 mEq/L → potassium chloride 10 mEq/hour IV and defer insulin until potassium is corrected; insulin can worsen hypokalemia.
Do not use a pump bolus to “correct” severe hyperglycemia or ketosis until delivery failure, ketones, and the patient’s ability to self-manage have been assessed.
Definitive Care & Disposition
Treat DKA using a standard institutional protocol; identify and correct the precipitant (e.g., kinked/dislodged set, empty reservoir, failed site, infection). Do not restart the pump until the patient is clinically stable, able to manage it, and the device/site have been reviewed with diabetes support. When transitioning from IV insulin, ensure basal coverage is established before stopping the infusion; basal dose and overlap depend on the patient’s regimen and protocol. Admit patients with DKA or unresolved delivery failure; involve endocrinology/diabetes educators when available.
How This One Kills
Simply disconnecting a pump without replacing basal insulin can precipitate rapid ketosis; trusting a pump that is malfunctioning can prolong insulin deprivation.
The Atypical Presentation
A patient may look well initially despite a recent interruption in rapid-acting insulin, and a normal CGM trace can lag behind changing blood glucose. Older or cognitively impaired users may not be able to describe basal settings, alarms, or infusion changes. Verify glucose, check ketones and acid–base status when symptoms or hyperglycemia suggest a problem, and never assume the pump is delivering insulin just because it is attached.
Back to Our Patient
Back to our 24-year-old with fever, nausea, high glucose, and a vibrating pump: verify his glucose, ketones, acid–base status, and potassium, while inspecting the device and infusion site. If he has DKA or cannot safely manage the pump, stop pump delivery and treat according to DKA severity; start IV insulin only after potassium is above 3.5 mEq/L, adding dextrose as indicated. Look for infection or infusion-set failure as the precipitant. Admit for ongoing treatment and do not restart the pump until he is stable, capable of managing it, and a safe transition plan is in place.
Patient Presentation to Attending
“This is a 24-year-old man with type 1 diabetes on an insulin pump, presenting after two days of fever and nausea. He reports not changing his tubing since yesterday, and the device is alarming; he has [last documented insulin delivery] and [ketones or symptoms]. He is [mental status and volume status], with glucose [value], potassium [value], bicarbonate [value], pH [value], and beta-hydroxybutyrate [value]. I’m concerned for pump delivery failure with [or without] DKA, possibly precipitated by infection. If DKA is present, I’ll stop the pump and use protocolized IV insulin once potassium is safe, with dextrose as needed. He needs [monitored admission/ICU] and a supervised plan for resuming basal insulin and pump use.”
Study Directive
Practice a focused pump history: last delivery, basal settings, boluses, alarms, site change, supplies, and CGM accuracy.
From memory, state when to stop pump use and how to avoid a basal-insulin gap during transition.
Review your hospital policy for personal pump/CGM use, device documentation, and coordination with the diabetes team.
Key Medications
Regular insulin IV: 0.1 units/kg/hour for DKA once potassium is above 3.5 mEq/L; use a protocol for titration and transition.
Potassium chloride: 10 mEq/hour IV if K <3.5 mEq/L while insulin is held; otherwise replace according to serial levels and protocol.
Dextrose for hypoglycemia: 25 g IV, using an appropriate concentration; if no IV access, glucagon 1 mg IM/SC.
Oral glucose: 15–20 g PO for an awake patient with hypoglycemia; recheck in 15 minutes.
Pump settings and long-acting basal replacement are patient-specific; do not guess. Confirm with the patient’s device record, diabetes team, or institutional protocol. Pediatric dosing and pump management are weight- and device-specific.
High-Yield Pearls
Pump interruption removes rapid-acting insulin without leaving a long-acting depot; ketosis can develop quickly.
If the patient is not able to operate the pump reliably, a pump download or family report does not make continued use safe.
The Mimics
CGM lag or sensor error — confirm urgent decisions with point-of-care glucose; treating a false reading can cause dangerous over- or under-correction.
Infusion-site failure — ketones and hyperglycemia despite reported boluses point to absent delivery; repeated pump corrections may not reach the patient.
Infection-related insulin resistance — fever or a focal infectious source can drive hyperglycemia despite an intact pump; focusing only on device settings misses the trigger.
Starvation ketosis — ketones without substantial acidosis may reflect poor intake; confusing it with pump-related DKA can lead to inappropriate insulin management.
Board Question
A pump-dependent patient with DKA has a potassium of 3.2 mEq/L. What is the best next step? -
AContinue the pump and give an IV insulin bolus -
BBegin IV insulin at 0.1 units/kg/hour immediately -
CReplace potassium and defer insulin until K is above 3.5 mEq/L -
DStop all insulin until the anion gap closes
Reveal answer
Correct: C
Insulin shifts potassium intracellularly and can worsen hypokalemia, so replace potassium first when K is below 3.5 mEq/L. Once corrected, begin protocolized insulin and ensure the pump is not being relied on during DKA.
Pump users can develop ketoacidosis quickly if insulin delivery stops, so assess the device and provide alternative insulin promptly when pump failure is suspected.
A quick test of recall from prior editions. Commit to an answer before you check.
From yesterday's edition
A 44-year-old woman treated with methadone and ondansetron becomes lightheaded, then briefly loses consciousness. The monitor shows a rapid wide-complex rhythm whose QRS axis appears to twist above and below the baseline. What’s the diagnosis, and the first move?
Check your answer
Torsades de Pointes. If pulseless or unstable, defibrillate. If perfusing, give magnesium sulfate 2 g IV, correct potassium/magnesium, stop QT-prolonging drugs, and consider overdrive pacing or isoproterenol for recurrent pause-dependent episodes.
From the September 30 edition
Today, three days ago: Norepinephrine. What’s the adult ED dose, and the contraindication you’d most regret missing?
Check your answer
Start 0.05–0.1 mcg/kg/min (≈ 5–8 mcg/min in adult); titrate q2–5 min to MAP ≥ 65 mmHg. Typical max 1–2 mcg/kg/min before adding a second agent. Profound hypovolemia (treat volume deficit first or simultaneously) and mesenteric/peripheral vascular thrombosis are relative.
From the September 23 edition
A 72-year-old with fever, hypotension, and flank pain has a ureteral stone with hydronephrosis on CT. After cultures and IV antibiotics, what is the next essential intervention?
ADischarge with oral antibiotics and medical expulsive therapy
BUrgent urinary decompression
CRepeat CT after 24 hours of antibiotics
DImmediate extracorporeal shock-wave lithotripsy
Reveal answer
Correct · B
An infected obstructed collecting system requires urgent drainage by ureteral stent or nephrostomy in addition to antibiotics. Antibiotics alone do not provide source control.
Journal Watch
From the FOAMed wireExtended window
Notable posts and reviews from the last week, ranked by relevance to today’s lead and source trust.
Evidence-based protocols include smart dosing, pharmacokinetics, and safe disposition. The post Phenobarbital for Alcohol Withdrawal in the ED: When, Why, and How? appeared first on ACEP Now .
Capture every RVU you earn. Master these four high-yield MDM documentation habits to optimize ED chart levels under the 2023 E/M reimbursement guidelines. The post Coding Wizard: Make Your Medical Decision Making Count with 9928X appeared first on ACEP Now .
Podcast Picks
Two for the shiftExtended
Critical Care Perspectives in Emergency Medicine2026-09-01
Brain damage and death from ischemic encephalopathy is common after cardiac arrest. Animal studies and limited observational studies suggest that high oxygen exposure after ROSC may result in neuronal death. As such, it is hypothesized that limiting oxygen exposure (conservative oxygen) many attenuate reperfusion injury and improve outcomes. At present,...
Source
Critical Care Perspectives in Emergency Medicine
Published
2026-09-01
Host
Critical Care Perspectives in Emergency Medicine, Critical Care Perspectives in Emergency Medicine
Meet L.I.F.T. (Low acuity, Immediate care, Fast track, and Telehealth)! September topics include chest pain, seizures, PID, migraine guidelines, and pediatric swollen joints. 1. September Introduction: Meet L.I.F.T....
UMEM Pearl
Matched to today’s topics
A clinical pearl from the University of Maryland EM group’s Educational Pearls, tied to today’s differential.
In euglycemic DKA, the usual glucose threshold (>250 mg/dL) is misleading; acidosis and elevated beta-hydroxybutyrate remain the diagnostic anchors.
This single center study looked at diabetic patients who had a POC glucose over 300 and POC ketone over 1.1 and reviewed their diagnosis vs the laboratory accepted diagnosis of DKA. “The most recent international consensus laboratory definition of (non-euglycemic) DKA includes a glucose of >?250; a pH 7.3 or a bicarbonate ??18?mmol/L; and a beta-hydroxybutyrate (BOHB) ??3.0?mmol/L or urine ketone strip ??2+”
Critical Care Corner
Matched to today’s topics
A critical-care reference from LITFL’s Critical Care Compendium, tied to today’s differential.
In acute hypocalcemia, distinguishing redistribution from true calcium loss helps guide repletion and treatment of the underlying cause.
Hypocalcaemia: Reduced intake; redistribution and increased output
Pharmacology Corner
Two drugs for the shift
One antimicrobial and one other ED workhorse — selected daily, with sources and last-reviewed dates so every dose is cross-checkable.
Antimicrobial of the Day
Cephalexin
First-generation cephalosporin
Indication
Outpatient non-purulent cellulitis and other MSSA/streptococcal SSTI, streptococcal pharyngitis, uncomplicated cystitis, and impetigo. Not MRSA-active.
What’s your dose? — reveal dosing & cautions
ED Dose
500 mg PO q6h (q12h for milder infections). Cellulitis: 500 mg PO QID. Strep pharyngitis: 500 mg PO BID x10 days. Pediatric: 25–50 mg/kg/day divided q6–12h.
Renal Adjustment
Reduce dose/frequency in CrCl < 30 mL/min (e.g. extend interval). HD: dose after dialysis.
Contraindications
Cephalosporin hypersensitivity. Use caution with documented severe (anaphylactic) penicillin allergy, though cross-reactivity with first-generation cephalosporins is low.
Interactions
Probenecid increases levels; metformin concentrations may rise.
Monitoring
Clinical response, GI tolerance; renal function in CKD.
ED Pearl
Covers MSSA and strep but NOT MRSA — a purulent abscess or cellulitis needs MRSA coverage (TMP-SMX or doxycycline), not cephalexin alone.
ED Pearl
The succinylcholine question is not ‘fast or not’; it is ‘does this patient have a reason to dump potassium and arrest?’ Burns, crush, denervation, and neuromuscular disease matter.
For educational use only. Verify dosing against the FDA label and your institution’s pharmacy resources before administering.
ECG of the Day
Preexcitation
Pre-excitation Syndromes (WPW)
A short PR, a slurred delta-wave upstroke, and a widened QRS mean an accessory pathway — and a tracing that mimics infarction and hypertrophy.
The Tracing
A 24-year-old man presents after a self-terminating episode of palpitations, now asymptomatic with normal vitals. His resting 12-lead is unusual: the PR interval is strikingly short, under 120 ms, and the initial upstroke of each QRS is not sharp but slurred, rising slowly before the complex takes off. The QRS is broadened, though not as wide as a bundle branch block, and the ST segments and T waves point opposite to the main QRS deflection. There is a dominant R wave in V1 with T-wave inversions in the right precordial leads, and a negative deflection at the start of the complex in aVL that could be mistaken for an old lateral Q wave.
Delta wave: slurred, slow-rising initial portion of the QRS
QRS prolongation > 110 ms, but less broad than in bundle branch block
Discordant ST-segment and T-wave changes (opposite to the major QRS component)
Pseudo-infarction pattern in up to 70% (negative delta waves creating pseudo-Q waves; dominant R wave in V1-3 mimicking posterior MI or RVH); left-sided AP gives R/S > 1 in V1 (type A), right-sided gives a negative delta in V1-2 (type B)
Pearls
The delta wave is just early ventricular activation via the bypass tract; abnormal depolarization forces abnormal, discordant repolarization — understanding the mechanism makes the ST/T changes expected rather than alarming.
Pre-excitation can be subtle or intermittent and may become more obvious with increased vagal tone or AV blockade (e.g. Valsalva or nodal-blocking drugs).
A concealed pathway conducts only retrograde, so the sinus-rhythm ECG is completely normal — a clean tracing does not exclude an accessory pathway in a patient with documented SVT.
Pitfalls
Reading the pseudo-infarction Q waves (e.g. in aVL) or the dominant V1-3 R waves as an old MI or ventricular hypertrophy that isn't there.
In pediatric ECGs the changes are subtle and normal-variant patterns (RSR' with T inversion in V1-2, or a dominant V1 R wave) overlap with WPW — look specifically for delta-wave slurring.
Overcalling Lown-Ganong-Levine on a short PR with normal QRS — the term should not be applied without paroxysmal tachycardia, and its existence is disputed.
At the Bedside
Identify the accessory pathway on the resting tracing so that, if this patient returns in a tachyarrhythmia, you are prepared — pre-excited atrial fibrillation and AVRT change management, and AV-nodal blockers can be dangerous in pre-excited AF; arrange cardiology/electrophysiology follow-up for a symptomatic patient.